null

Anti-Mouse CD178 (FasL) In Vivo Antibody - Low Endotoxin (IVMB0383)

SKU:
IVMB0383
Antibody Type:
Functional-Grade In Vivo Antibody
Disease Area:
Cancer
Clone:
MFL3
Protein:
CD178
Isotype:
IgG
Reactivity:
Mouse
Synonyms:
Fas Ligand
Apo-1 Ligand
CD95 Ligand
TNFSF6
Research Area:
Apoptosis
Cell Biology
Cell Death
Immunology
Neuroscience
Tumor Suppressors
Endotoxin Level:
Low Endotoxin
Host Species:
Armenian Hamster
Applications:
Blocking
FC
IF
In Vivo
€159 - €3,789

Description

Product Name:Anti-Mouse CD178 (FasL) In Vivo Antibody - Low Endotoxin
Product Code:IVMB0383
Size:1 mg, 5 mg, 25 mg, 50 mg, 100 mg
Clone:MFL3
Protein:CD178
Product Type:Monoclonal Antibody
Synonyms:FasL, Fas Ligand, FasL, Apo-1 Ligand, CD95 Ligand, TNFSF6
Isotype:IgG
Reactivity:Mouse
Applications:B, FC, IF, In Vivo
Formulation:This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Endotoxin Level:< 1.0 EU/mg as determined by the LAL method
Purity:≥95% monomer by analytical SEC â‹… >95% by SDS Page
Product Preparation:Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Applications:B, FC, IF, In Vivo
Reactivity:Mouse
Host Species:Armenian Hamster
Specificity:Clone MFL3 recognizes an epitope on mouse FasL.
Antigen Distribution:FasL is expressed on activated T cells, NK cells, the eye, and testis.
Immunogen:B6 mouse FasL cDNA-transfected baby hamster kidney (B6 FasL/BHK) cells
Concentration:≥ 5.0 mg/ml
Endotoxin Level:< 1.0 EU/mg as determined by the LAL method
Formulation:This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Purity:≥95% monomer by analytical SEC â‹… >95% by SDS Page
Preparation:Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling:Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

FasL antibody, clone AFS98, recognizes Fas ligand (FasL), also known as CD178, Apo-1 ligand, and CD95 ligand. FasL is a 40 kDa type II integral membrane protein that belongs to the tumor necrosis factor (TNF) superfamily. FasL is expressed by activated T cells and natural killer (NK cells)1-3. Binding of FasL to its receptor Fas (CD95, APO-1) induces apoptotic cell death in Fas-expressing target cells, contributing to anti-viral immunity. FasL also contributes to peripheral tolerance and the downregulation of immune responses through activation-induced autocrine and paracrine T cell death4. FasL is also found in the anterior chamber of the eye and on Sertoli cells in the testis, and is implicated in immune-privilege at these sites5,6. FasL also contributes to CD8 proliferation and neutrophil recruitment7,8. Soluble FasL (26 kDa) can be released following cleavage by metalloproteinases and block FasL-mediated signaling9. Fas/FasL-signaling is involved in the development of many human diseases, including autoimmunity and cancer10. Many human tumors over-express FasL, resulting in tumor infiltrating lymphocyte (TIL) apoptosis and immune evasion, which is associated with poor prognosis11-14.

Protein:CD178
Ligand/Receptor:Fas (CD95)
Research Area:Apoptosis, Cell Biology, Cell Death, Immunology, Neuroscience, Tumor Suppressors
Shipping:2-8°C
PubMed:CD178
NCBI Gene Bank ID:14103

Related Products